Heartflow, Inc. $HTFL Shares Purchased by Eventide Asset Management LLC

Eventide Asset Management LLC increased its holdings in shares of Heartflow, Inc. (NASDAQ:HTFL) by 502.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 505,989 shares of the company’s stock after acquiring an additional 421,999 shares during the period. Eventide Asset Management LLC owned approximately 0.59% of Heartflow worth $14,750,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Heartflow during the 4th quarter valued at about $27,000. Legal & General Group Plc acquired a new stake in shares of Heartflow during the 3rd quarter valued at about $59,000. Strs Ohio acquired a new stake in shares of Heartflow during the 4th quarter valued at about $99,000. Police & Firemen s Retirement System of New Jersey acquired a new stake in shares of Heartflow during the 4th quarter valued at about $131,000. Finally, Staley Capital Advisers Inc. acquired a new stake in shares of Heartflow during the 4th quarter valued at about $204,000.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on HTFL shares. JPMorgan Chase & Co. decreased their price target on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research note on Thursday, March 19th. Canaccord Genuity Group decreased their price target on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating on the stock in a research note on Friday, May 15th. William Blair started coverage on shares of Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating on the stock. Wells Fargo & Company raised their price target on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, Piper Sandler reaffirmed an “overweight” rating on shares of Heartflow in a research note on Thursday. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $37.00.

Heartflow Price Performance

HTFL opened at $33.24 on Monday. The company’s 50 day simple moving average is $29.30 and its two-hundred day simple moving average is $28.32. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $41.22. The firm has a market capitalization of $2.87 billion and a price-to-earnings ratio of -10.69.

Heartflow (NASDAQ:HTFL) last released its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The business’s revenue for the quarter was up 41.3% compared to the same quarter last year. On average, equities analysts anticipate that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Insider Transactions at Heartflow

In other news, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $29.23, for a total transaction of $27,732,167.11. Following the completion of the sale, the insider owned 8,448,158 shares in the company, valued at $246,939,658.34. This trade represents a 10.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the sale, the insider owned 78,731 shares of the company’s stock, valued at $2,231,236.54. This represents a 10.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,215,696 shares of company stock worth $64,552,076 in the last 90 days. Insiders own 7.70% of the company’s stock.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.